Methotrexate Injection Usp 25mg/ml (2017-07-17)

Methotrexate Injection USP 25mg/ml Recall Methotrexate Injection USP 25mg/ml has been recalled across Canada due to product safety concerns. This recall affects all patients and healthcare facilities who have or may use this medication. The product has been classified as a Class I recall, which indicates a serious safety issue.

Reason
Product safety
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2017-10-04
Status
Closed
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7520dc50-05c2-4e59-b505-6cccffeee3cb